Creating Your Career Niche At The Interface Of Bioscience And Medicine

Creating Your Career Niche at the Interface of Bioscience and Medicine

Tuesday, October 26, 2010, 5:30-8:30 pm
Keith Flaherty, MD
Lecturer, Department of Medicine, Harvard Medical School; Director of Developmental Therapeutics, Cancer Center, Massachusetts General Hospital

(download flyer)

You’ve seen the constant evolution accelerate in biomedical, pharmaceutical and medical research. How do you get to be one of those game changers? Barriers to new technologies in any area arise from a lack of understanding and new vocabulary. Where interfaces exist between disciplines, there is a constant unmet need for translators who can communicate with both sides. Keith will show you how you can identify these frontiers for yourself to make the foundation for a career path that is self-renewing and always in demand.

Keith received a BS from Yale University and MD from Johns Hopkins University. He trained in internal medicine at Brigham and Women’s Hospital and held a fellowship in medical oncology at the University of Pennsylvania. He joined the faculty in the School of Medicine at the University of Pennsylvania as Assistant Professor of Medicine and member of the Developmental Therapeutics in 2002. In 2009, he moved to lead the Developmental Therapeutics Program in the Massachusetts General Hospital Cancer Center.

Keith is PI of numerous first-in-human clinical trials for novel targeted therapies, and is the PI of national, cooperative group trials for phase III sorafenib in combination therapy for metastatic melanoma and a phase II trial comparing anti-angiogenic agents in metastatic renal cell carcinoma. Dr. Flaherty has led the clinical development of the first three Raf inhibitors, ultimately validating mutated BRAF as a therapeutic target in cancer. He is internationally known for expertise in clinical and translational research directed against signal transduction pathways in melanoma. Dr. Flaherty currently maintains a clinical focus on melanoma and renal cell carcinoma, with an overall emphasis on developing novel therapies for these historically treatment-refractory malignancies.

Registration:
$35 online (until October 25), $20 student
$40 onsite, $25 student/affiliate

choose ticket

Admission includes a light dinner and drinks from 5:30 – 6:30 pm. Program begins at 6:30 pm

Sponsor: University of San Diego, School of Business Administration

Location: Knobbe Martens

12790 El Camino Real, San Diego, CA 92130

From I-5 South:

  • Take Del Mar Heights Road Exit
  • Turn Left on Del Mar Heights Road
  • Turn Right on El Camino Real
  • 12970 El Camino Real is on the Right
From I-5 North:

  • Take Del Mar Heights Road Exit
  • Turn Right on Del Mar Heights Road
  • Turn Right on El Camino Real
  • 12970 El Camino Real is on the Right